[Diagnosis and therapy of Hodgkin's disease in Freiburg in Breisgau 1964 to 1976. 2. Results during the treatment period 1972-1976 compared with the period 1964-1971].

Strahlentherapie Pub Date : 1985-10-01
K Musshoff, V Weidkuhn, J Bammert, H U Felker
{"title":"[Diagnosis and therapy of Hodgkin's disease in Freiburg in Breisgau 1964 to 1976. 2. Results during the treatment period 1972-1976 compared with the period 1964-1971].","authors":"K Musshoff,&nbsp;V Weidkuhn,&nbsp;J Bammert,&nbsp;H U Felker","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The total group of patients with Hodgkin's disease submitted to primary treatment from May 1964 till December 1976 is divided with respect to diagnostics and therapy into a preponderantly clinically assessed group (CS) treated during the years of 1964 to 1971 (n = 190) and a preponderantly surgically assessed group (PS) treated during the years of 1972 to 1976 (n = 180). The first subgroup was treated with differently large irradiation fields and, in case of combined therapy, mostly with cyclophosphamide. The second subgroup was treated with extended fields, even until total lymphoid irradiation and, in case of drug administration, with primary combined chemotherapy (MOPP). The overall five-year remission rates of both subgroups (stages I to IV) have improved from 35.4% to 54.8% (P less than or equal to 0.001) and the five-year survival rates from 67.2% to 78.2% (P less than or equal to 0.001). If a complete remission was achieved, this was obtained, as far as judgeable, already at an earlier moment in the individual groups: e.g., in stage I with 95.5% after one year as against 94.1% after five years and in stage II with 91.3% after four years as against 72.9% after seven years. The prognostic differences of stages I and II and the histologic manifestations: lymphocytic predominance, nodular sclerosis, and mixed cellularity were equalized under the therapeutic measures of the intensive treatment period.</p>","PeriodicalId":21981,"journal":{"name":"Strahlentherapie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1985-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Strahlentherapie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The total group of patients with Hodgkin's disease submitted to primary treatment from May 1964 till December 1976 is divided with respect to diagnostics and therapy into a preponderantly clinically assessed group (CS) treated during the years of 1964 to 1971 (n = 190) and a preponderantly surgically assessed group (PS) treated during the years of 1972 to 1976 (n = 180). The first subgroup was treated with differently large irradiation fields and, in case of combined therapy, mostly with cyclophosphamide. The second subgroup was treated with extended fields, even until total lymphoid irradiation and, in case of drug administration, with primary combined chemotherapy (MOPP). The overall five-year remission rates of both subgroups (stages I to IV) have improved from 35.4% to 54.8% (P less than or equal to 0.001) and the five-year survival rates from 67.2% to 78.2% (P less than or equal to 0.001). If a complete remission was achieved, this was obtained, as far as judgeable, already at an earlier moment in the individual groups: e.g., in stage I with 95.5% after one year as against 94.1% after five years and in stage II with 91.3% after four years as against 72.9% after seven years. The prognostic differences of stages I and II and the histologic manifestations: lymphocytic predominance, nodular sclerosis, and mixed cellularity were equalized under the therapeutic measures of the intensive treatment period.

[1964年至1976年在布列斯高弗莱堡霍奇金病的诊断和治疗]。2. 1972-1976年治疗期与1964-1971年治疗期比较结果。
从1964年5月至1976年12月接受初级治疗的霍奇金病患者的总组根据诊断和治疗分为在1964年至1971年间接受治疗的主要临床评估组(CS) (n = 190)和在1972年至1976年间接受治疗的主要手术评估组(PS) (n = 180)。第一个亚组用不同大小的照射场治疗,在联合治疗的情况下,主要使用环磷酰胺。第二亚组接受扩大视野的治疗,直至淋巴细胞全照射,在给药的情况下,接受初级联合化疗(MOPP)。两个亚组(I至IV期)的总5年缓解率从35.4%提高到54.8% (P小于等于0.001),5年生存率从67.2%提高到78.2% (P小于等于0.001)。如果实现了完全缓解,就可判断而言,在个体组中已经在较早的时刻获得了完全缓解:例如,I期患者一年后的缓解率为95.5%,五年后为94.1%;II期患者四年后的缓解率为91.3%,七年后为72.9%。在强化治疗期的治疗措施下,I期和II期的预后差异及组织学表现:淋巴细胞为主、结节性硬化、混合细胞化均相等。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信